Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.3 % |
3 Month Return | -1.35 % |
1 Year Return | + 34.75 % |
Market Stats | |
Previous Close | ₹251.65 |
Open | ₹252.45 |
Volume | 4,401.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹504.61Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹504.61 Cr |
P/B Ratio | 7.09 |
EPS | 2.76 |
Dividend Yield | 0 |
Sector | Miscellaneous |
ROE | 14.07 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹504.61 Cr | 124.67% | 0.60 | ₹5 Cr | ₹50 Cr | |
NA | ₹224.61 Cr | 24.96% | 0.50 | ₹1 Cr | ₹98 Cr | |
NA | ₹222.10 Cr | 68.31% | 0.71 | ₹5 Cr | ₹245 Cr | |
NA | ₹1,414.68 Cr | 665.55% | 0.52 | ₹9 Cr | ₹52 Cr | |
NA | ₹1,554.86 Cr | 338.77% | 0.69 | NA | NA |
Organisation | Indo US Bio-Tech Ltd |
Headquarters | |
Industry | Miscellaneous |
E-voting on shares | Click here to vote |
Key events for Indo US Bio-Tech Ltd
Indo US Bio-Tech shares rose 3% after the company announced an interim dividend of Rs 0.25 per equity share for FY25, with payment scheduled by December 19, 2024.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, INDOUS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
Price Rise
In the last 3 years, INDOUS stock has moved up by 479.6%
Against Peers
In the last 1 year, Vimta Labs Ltd has given 73.3% return, outperforming this stock by 38.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.17% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 29.83% of holdings in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 70.17% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 29.83% | 0.00 | |
Others | 0% | 0.00 |
Indo US Bio-Tech Ltd’s net profit jumped 161.08% since last year same period to ₹4.36Cr in the Q2 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 37.54% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2021, Indo US Bio-Tech Ltd has declared dividend of ₹0.25 - translating a dividend yield of 0.10%.
Read More about DividendsBearish
Neutral
Bullish
Indo US Bio-Tech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Indo US Bio-Tech Ltd (INDOUS) share price today is ₹246.65
Indo US Bio-Tech Ltd is listed on NSE
Indo US Bio-Tech Ltd is listed on BSE
Today’s traded volume of Indo US Bio-Tech Ltd(INDOUS) is 4,401.00.
Today’s market capitalisation of Indo US Bio-Tech Ltd(INDOUS) is ₹504.61Cr.
Indo US Bio-Tech Ltd(INDOUS | Price |
---|---|
52 Week High | ₹331.8 |
52 Week Low | ₹222 |
Indo US Bio-Tech Ltd(INDOUS) share price is ₹246.65. It is down -25.66% from its 52 Week High price of ₹331.8
Indo US Bio-Tech Ltd(INDOUS) share price is ₹246.65. It is up 11.10% from its 52 Week Low price of ₹222
Indo US Bio-Tech Ltd(INDOUS | Returns |
---|---|
1 Day Returns | -5% |
1 Month Returns | -3.3% |
3 Month Returns | -1.35% |
1 Year Returns | 34.75% |